What Is the Program?
How the Program Works
Who We Are
News & Resources
Contact

Menu

What Is the Program?
How the Program Works
Who We Are
News & Resources
Contact

Search

Close

Mectizan Program Notes – Winter 2020

March 31, 2020
MDP Newsletter

For more information, please download and read the attached PDF.

Mectizan Program Notes - Winter 2020|Mectizan Program Notes - Winter 2020|Mectizan Program Notes - Winter 2020

Share This Post:

Facebook

Twitter

LinkedIn

Email

Print

Get Our Newsletter

Sign up for quarterly updates and breaking news

The Mectizan Donation Program is an international program to eliminate river blindness and lymphatic filariasis (LF), primarily funded by Merck & Co., Inc., Rahway, N.J., U.S.A.,* with additional support from GSK. For LF, Mectizan® is co-administered with albendazole, which is donated by GSK. | *Merck is known as MSD outside the USA and Canada.

Get in Touch

mectizan@taskforce.org
Tel. 1-404-371-1460
Fax 1-404-371-1138
330 West Ponce de Leon Avenue | Decatur, Georgia 30030 | USA

What Is The Program?

Overview
History Of The Program
Lymphatic Filariasis
River Blindness
The Medicines
Where We Work

Quick Links

How the Program Works
News from MDP
Resources
Meet Our Partners
Disclaimer
Contact Us

Facebook Instagram Twitter Vimeo

© 2023 Mectizan Donation Program ®

Mectizan Expert Committee (MEC) Statement on Mectizan® Use During the COVID-19 Pandemic